Get started
Author

Polina Todorova

Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—a randomized controlled trial
2023 · Sadrija Cukoski, Christoph Heinrich Lindemann, et al. · Cell Reports Medicine · 77
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease
2022 · Simon Oehm, Konstantin Steinke, et al. · Nephrology Dialysis Transplantation · 45
PDF
Impairment of Neurocognitive Functioning, Motor Performance, and Mood Stability in Hospitalized Patients With Euvolemic Moderate and Profound Hyponatremia
2020 · Victor Suárez, Dario Norello, et al. · The American Journal of Medicine · 43
Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange
2024 · Lucas Kühne, Paul Knöbl, et al. · Blood · 40
SGLT2-Inhibition in Patients With Alport Syndrome
2024 · Jan Boeckhaus, Daniel P. Gale, et al. · Kidney International Reports · 30
PDF
Chronic Hyponatremia and Brain Structure and Function Before and After Treatment
2024 · Victor Suárez, Rosanne Picotin, et al. · American Journal of Kidney Diseases · 26
PDF
Preoperative Short‐Term Restriction of Sulfur‐Containing Amino Acid Intake for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Double‐Blind, Translational Trial
2022 · Thomas Osterholt, Claas Gloistein, et al. · Journal of the American Heart Association · 20
Cardiac Manifestations in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single-Center Study
2022 · Sita Arjune, Franziska Grundmann, et al. · Kidney360 · 18
Liver manifestations in autosomal dominant polycystic kidney disease (ADPKD) and their impact on quality of life
2024 · Sita Arjune, Polina Todorova, et al. · Clinical Kidney Journal · 13
PDF
Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS
2023 · Thomas Osterholt, Polina Todorova, et al. · Scientific Reports · 13
PDF
Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial
2026 · Ravi Thadhani, Thomas F. Hiemstra, et al. · Nature Medicine · 12
Inflammatory Cytokine Levels in Patients with Autosomal Dominant Polycystic Kidney Disease
2024 · Sita Arjune, Katharina Lettenmeier, et al. · Kidney360 · 12
DKK3 as a potential novel biomarker in patients with autosomal polycystic kidney disease
2023 · Sita Arjune, Martin R Späth, et al. · Clinical Kidney Journal · 12
PDF
Interaction Between Determinants Governing Urine Volume in Patients With ADPKD on Tolvaptan and its Impact on Quality of Life
2023 · Polina Todorova, Sita Arjune, et al. · Kidney International Reports · 12
PDF
Copeptin in autosomal dominant polycystic kidney disease: real-world experiences from a large prospective cohort study
2023 · Sita Arjune, Simon Oehm, et al. · Clinical Kidney Journal · 11
PDF
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study
2022 · Alexander Fuchs, Jennifer Dederichs, et al. · Clinical Kidney Journal · 9
PDF
HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial
2024 · Thomas Bais, Esther Meijer, et al. · Trials · 7
PDF
A Low-Cost Sequencing Platform for Rapid Genotyping in ADPKD and its Impact on Clinical Care
2022 · Christoph Heinrich Lindemann, Andrea Wenzel, et al. · Kidney International Reports · 5
PDF
Cyst Fraction as a Biomarker in Autosomal Dominant Polycystic Kidney Disease
2022 · Larina A. Karner, Sita Arjune, et al. · Journal of Clinical Medicine · 4
PDF
The Gut Microbiome in Autosomal Dominant Polycystic Kidney Disease
2025 · Fabian Woestmann, Sebastian Strubl, et al. · Kidney360 · 2
#395 Gut dysbiosis in ADPKD patients: a controlled pilot study
2024 · Sebastian Strubl, Fabian Woestmann, et al. · Nephrology Dialysis Transplantation · 2
MO016: Feasibility and Effectiveness of Short-Term Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease (ADPKD): Results from the Reset-Pkd Study
2022 · Simon Oehm, Konstantin Steinke, et al. · Nephrology Dialysis Transplantation · 1
MEDA-PKD: a dynamic, real-time analytics platform for precision care in autosomal dominant polycystic kidney disease
2026 · Franziska Grundmann, Sita Arjune, et al. · npj Digital Medicine
PDF
Forschungsnetzwerk Nephrogeriatrie – interdisziplinär mehr erreichen
2026 · Maximilian König, Anna Maria Affeldt, et al. · Die Innere Medizin
Real-Time Platform for Data Analysis and Visualization in ADPKD: Insights from a Large Prospective Cohort Study
2025 · Roman-Ulrich Mueller, Franziska Grundmann, et al. · Journal of the American Society of Nephrology
Works count: 34
Citation count: 414
H-index: 12
I10-index: 15
Year
Topic
Type